Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns 
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results 
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported 
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens 
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations 
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users 
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium 
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback 
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations 
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts 
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook 
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks 
CARLSBAD, Calif., March 01, 2018 -- Alphatec Holdings, Inc. (Nasdaq:ATEC) (the “Company”), the parent company of Alphatec Spine, Inc., a provider of spinal fusion technologies, announced today that the Company plans to release its fourth quarter and fiscal year 2017 financial results on Thursday, March 8, 2018 after the market closes.
The Company will hold a conference call on Thursday, March 8, 2018 at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results. The dial-in numbers are (877) 556-5251 for domestic callers and (720) 545-0036 for international callers. The conference ID number is 7887979. A live webcast of the conference call will be available online from the investor relations page of the Company's corporate website at www.alphatecspine.com.
A replay of the webcast will remain available on the Company’s website, www.alphatecspine.com, until the Company releases its second quarter 2017 financial results. In addition, a telephonic replay of the call will be available until August 17, 2017. The replay dial-in numbers are (855) 859-2056 for domestic callers and (404) 537-3406 for international callers. Please use the replay conference ID number 7887979.
About Alphatec Holdings, Inc.
Alphatec Holdings, Inc., through its wholly-owned subsidiary of Alphatec Spine, Inc., is a medical device company that designs, develops and markets spinal fusion technology products and solutions for the treatment of spinal disorders associated with disease and degeneration, congenital deformities and trauma. The Company's mission is to improve lives by providing innovative spine surgery solutions through the relentless pursuit of superior outcomes. The Company markets products in the U.S. via independent sales agents and a direct sales force.
Additional information can be found at www.alphatecspine.com.
Investor/Media Contact:
Carol Ruth
The Ruth Group
(646) 536-7000
[email protected]
Company Contact:
Jeff Black
Executive Vice President and CFO
Alphatec Holdings, Inc.
[email protected]
